National Natural Science Foundation of China (no. 82102088,
81971642, 82001861), Capital’s Funds for Health Improvement and Research
(no. 2020-2-2025), and National Key Research and Development Plan (no.
2020YFC0122000).
第一作者单位:[1]Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China
通讯作者:
通讯机构:[1]Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China[*1]Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, 95 Yong An Rd, Xi Cheng District, Beijing 100050, China
推荐引用方式(GB/T 7714):
Feng Lijuan,Yang Xu,Lu Xia,et al.Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18F-FDG PET/CT[J].Clinical Nuclear Medicine.2022,doi:10.1097/RLU.0000000000004337.
APA:
Feng Lijuan,Yang Xu,Lu Xia,Wang Wei&Yang Jigang.(2022).Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18F-FDG PET/CT.Clinical Nuclear Medicine,,
MLA:
Feng Lijuan,et al."Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18F-FDG PET/CT".Clinical Nuclear Medicine .(2022)